Arbutus Biopharma Corporation (NASDAQ:ABUS) Q2 2019 Results Earnings Conference Call August 5, 2019 8:45 AM ET Company Participants Pam Murphy - IR Consultant William Collier - President, CEO David Hastings - CFO & CAO Gaston Picchio - Chief Development Officer Michael Sofia - Chief Scientific Officer Conference Call Participants Keay Nakae - Chardan Jeffrey Tan - B. Riley FBR Operator Good day, ladies and gentlemen, and welcome to the Arbutus Biopharma Corporation 2019 Second Quarter Financial Results and ...